Estimate the probability and timeline of UCTD evolution to a defined connective tissue disease (CTD) using clinical features, autoantibody profile, and disease duration. 30-40% of UCTD evolves within 5 years.
Estimate the probability and timeline of UCTD evolution to a defined connective tissue disease (CTD) using clinical features, autoantibody profile, and disease duration. 30-40% of UCTD evolves within 5 years
Each component has a specific meaning:
Note: Interpret the uctd risk score result against the thresholds and context described above.
Enter the clinical features, autoantibody profile, disease duration for the scenario you are assessing. Estimate the probability and timeline of UCTD evolution to a defined connective tissue disease (CTD) using clinical features, autoantibody profile, and disease duration. 30-40% of UCTD evolves within 5 years. Use the uctd risk score result to inform your calculation.